Marrone Bio Innovations Inc Revenue Growth Rates (MBII), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Marrone Bio Innovations Inc   (NASDAQ: MBII)
 

MBII's Revenue Growth by Quarter and Year

Marrone Bio Innovations Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MBII Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 11.10
FY 11.10

MBIIs Annual Revenue
Marrone Bio Innovations Inc 's Revenue in the fiscal year 2021 $ 44.31 millions
Marrone Bio Innovations Inc 's Revenue in the fiscal year 2020 $ 38.37 millions
Marrone Bio Innovations Inc 's Revenue in the fiscal year 2019 $ 29.37 millions
Marrone Bio Innovations Inc 's Revenue in the fiscal year 2018 $ 21.22 millions
Marrone Bio Innovations Inc 's Revenue in the fiscal year 2017 $ 18.17 millions




MBII Revenue first quarter 2022 Y/Y Growth Comment
Marrone Bio Innovations Inc reported Revenue growth of 0.52% year on year in the first quarter 2022, to $ 11.10 millions, this is lower than Marrone Bio Innovations Inc 's recent average Revenue improvement of 26.63%.

Looking into first quarter 2022 results within Agricultural Production industry 22 other companies have achieved higher Revenue growth. While Marrone Bio Innovations Inc ' s Revenue increase of 0.52% ranks overall at the positon no. 2841 in the first quarter 2022.


MBII Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter December - 40.16 % 15.4 % 16.96 %
3rd Quarter September - 11.66 % 26.69 % 28.36 %
2nd Quarter June - 3.45 % 74 % 21.74 %
1st Quarter March 0.52 % 14.4 % 10.67 % 101.85 %
FY   - 15.48 % 30.63 % -

Financial Statements
Marrone Bio Innovations Inc 's first quarter 2022 Revenue $ 11.10 millions MBII's Income Statement
Marrone Bio Innovations Inc 's first quarter 2021 Revenue $ 11.04 millions Quarterly MBII's Income Statement


MBII Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter December - 9.74 % -12.57 % -4.02 %
3rd Quarter September - -21.75 % -27.5 % -0.43 %
2nd Quarter June - 14.13 % 26.22 % -19.72 %
1st Quarter March 2.56 % 43.01 % 44.25 % 52.45 %
FY (Year on Year)   - 15.48 % 30.63 % -


Back to MBII Growth rate Comparisons >> Back to MBII Growth rate Comparisons >>


Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #23
Consumer Non Cyclical Sector #118
Overall #2841

Revenue Y/Y Growth Statistics
High Average Low
101.57 % 26.63 % -26.31 %
(Mar 31 2019)   (Mar 31 2015)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry #23
Consumer Non Cyclical Sector #118
Overall #2841
Revenue Y/Y Growth Statistics
High Average Low
101.57 % 26.63 % -26.31 %
(Mar 31 2019)   (Mar 31 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Marrone Bio Innovations Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
89.17 % 13 % -34.85 %
(Jun 30 2016)  


MBII's I. Quarter Q/Q Revenue Comment
Marrone Bio Innovations Inc achieved in the I. Quarter 2022 below company average Revenue growth of 2.56% quarter on quarter, to $ 11.10 millions.

Within Agricultural Production industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Marrone Bio Innovations Inc 's Revenue growth quarter on quarter, overall rank is 1566.


Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #21
Consumer Non Cyclical Sector #66
Overall #1566
Revenue Q/Q Growth Company Ranking
Within: No.
Agricultural Production Industry #21
Consumer Non Cyclical Sector #66
Overall #1566
Revenue Q/Q Growth Statistics
High Average Low
89.17 % 13 % -34.85 %
(Jun 30 2016)  


MBII's I. Quarter Q/Q Revenue Comment
Marrone Bio Innovations Inc achieved in the I. Quarter 2022 below company average Revenue growth of 2.56% quarter on quarter, to $ 11.10 millions.

Within Agricultural Production industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Marrone Bio Innovations Inc 's Revenue growth quarter on quarter, overall rank is 1566.


Marrone Bio Innovations Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 44.37 $ 44.31 $ 41.21 $ 40.18 $ 39.76
Y / Y Revenue Growth (TTM) 11.59 % 15.47 % 10.33 % 13.23 % 31.2 %
Year on Year Revenue Growth Overall Ranking # 1150 # 1974 # 1899 # 1599 # 500
Seqeuential Revenue Change (TTM) 0.13 % 7.52 % 2.56 % 1.06 % 3.62 %
Seq. Revenue Growth (TTM) Overall Ranking # 2812 # 965 # 2119 # 2669 # 1476


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2022 period, Marrone Bio Innovations Inc 's cumulative twelve months Revenue were $ 44 millions, company would post below average annual Revenue growth of 3.62% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Marrone Bio Innovations Inc 's Revenue growth from the 10.82% growth in Dec 31 2021.

In the Consumer Non Cyclical sector 44 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1150, from total ranking in previous quarter at 1974.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 22
Consumer Non Cyclical Sector # 45
Overall # 1150

Revenue TTM Y/Y Growth Statistics
High Average Low
378.1 %
 40.36 %
-51.95 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 107
S&P 500 # 2812
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2022 period, Marrone Bio Innovations Inc 's cumulative twelve months Revenue were $ 44 millions, company would post below average annual Revenue growth of -51.95% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Marrone Bio Innovations Inc 's Revenue growth from the 10.82% growth in Dec 31 2021.

In the Consumer Non Cyclical sector 44 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1150, from total ranking in previous quarter at 1974.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Agricultural Production Industry # 22
Consumer Non Cyclical Sector # 45
Overall # 1150

Revenue TTM Y/Y Growth Statistics
High Average Low
378.1 %
40.36 %
-51.95 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 107
S&P 500 # 2812




Other Revenue Growth
Agricultural Production Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MBII's Revenue Growth Ratio versus Agricultural Production Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2022 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Nutra Pharma Corp 0.79%$ 0.795 millions
Marrone Bio Innovations Inc 0.53%$ 0.535 millions


About Marrone Bio Innovations Inc Revenue Growth Rates (MBII), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Marrone Bio Innovations Inc (CIK 1441693).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-22-013374
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Marrone Bio Innovations Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.